Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Biosci ; 12(1): 110, 2022 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-35869491

RESUMO

BACKGROUND: Spastin significantly influences microtubule regulation in neurons and is implicated in the pathogenesis of hereditary spastic paraplegia (HSP). However, post-translational regulation of the spastin protein remains nebulous. The association between E3 ubiquitin ligase and spastin provides a potential therapeutic strategy. RESULTS: As evidenced by protein chip analysis, FBXL17 inversely correlated with SPAST-M1 at the protein level in vitro and, also in vivo during embryonic developmental stage. SPAST-M1 protein interacted with FBXL17 specifically via the BTB domain at the N-terminus of SPAST-M1. The SCFFBXL17 E3 ubiquitin ligase complex degraded SPAST-M1 protein in the nuclear fraction in a proteasome-dependent manner. SPAST phosphorylation occurred only in the cytoplasmic fraction by CK2 and was involved in poly-ubiquitination. Inhibition of SCFFBXL17 E3 ubiquitin ligase by small chemical and FBXL17 shRNA decreased proteasome-dependent degradation of SPAST-M1 and induced axonal extension. The SPAST Y52C mutant, harboring abnormality in BTB domain could not interact with FBXL17, thereby escaping protein regulation by the SCFFBXL17 E3 ubiquitin ligase complex, resulting in loss of functionality with aberrant quantity. Although this mutant showed shortening of axonal outgrowth, low rate proliferation, and poor differentiation capacity in a 3D model, this phenotype was rescued by inhibiting SCFFBXL17 E3 ubiquitin ligase. CONCLUSIONS: We discovered that a novel pathway, FBXL17-SPAST was involved in pathogenicity of HSP by the loss of function and the quantitative regulation. This result suggested that targeting FBXL17 could provide new insight into HSP therapeutics.

2.
ACS Appl Mater Interfaces ; 13(25): 29313-29324, 2021 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-34137258

RESUMO

Extracellular vesicles (EVs) with native membrane proteins possess a variety of functions. EVs have become increasingly important platforms for incorporating a new peptide/protein with additional functions on their membranes using genetic manipulation of producer cells. Although directly harnessing native membrane proteins on EVs for functional studies is promising, limited studies have been conducted to confirm its potential. This study reports bioengineered EVs with CD14, a natural glycosylphosphatidylinositol (GPI)-anchored protein and a selectively enriched native membrane protein on EVs. We demonstrated that producer cells transfected with genes encoding for GPI-anchored and transmembrane glycoproteins selectively display the former over the latter on bioengineered EVs. Furthermore, using specific enzyme cleavage studies, we characterized and validated that CD14 is indeed GPI-anchored on bioengineered EV membranes. Natural GPI-anchored proteins are conserved receptors for bacterial toxins; for example, CD14 is an innate immune receptor for lipopolysaccharide (LPS), a gram-negative bacterial endotoxin. We reported that unlike soluble CD14, bioengineered EVs harboring CD14 reduce (50-90%) LPS-induced cytokine responses in mouse macrophages, including primary cells, possibly by reduced cell surface binding of LPS. These findings highlight the importance of harnessing the native EV membrane proteins, like GPI-anchored proteins, for functional studies such as toxin neutralization. The GPI-anchoring platform can display various natural GPI-anchored proteins and other full-length proteins as GPI-anchored proteins on EV membranes.


Assuntos
Bioengenharia/métodos , Vesículas Extracelulares , Glicosilfosfatidilinositóis , Lipopolissacarídeos/metabolismo , Proteínas de Membrana , Animais , Técnicas de Visualização da Superfície Celular , Células Cultivadas , Vesículas Extracelulares/química , Vesículas Extracelulares/metabolismo , Feminino , Glicosilfosfatidilinositóis/química , Glicosilfosfatidilinositóis/metabolismo , Células HEK293 , Humanos , Macrófagos/citologia , Proteínas de Membrana/química , Proteínas de Membrana/metabolismo , Camundongos , Camundongos Endogâmicos BALB C
3.
Medicine (Baltimore) ; 100(1): e24185, 2021 Jan 08.
Artigo em Inglês | MEDLINE | ID: mdl-33429807

RESUMO

ABSTRACT: The hypocellular variant of acute myeloid leukemia (AML) is defined as bone marrow cellularity of <20% in a biopsy specimen at presentation. We performed a retrospective analysis of the clinical features and survival outcomes of hypocellular AML in a Korean population. We reviewed the medical records of all patients diagnosed with AML at nine hospitals participating in the Korean AML registry from 2006 to 2012. Overall survival (OS) and event-free survival (EFS) rates were calculated from the time of diagnosis until death or an event, respectively. In total, 2110 patients were enrolled and 102 (4.8%) were identified as having hypocellular AML. Patients with hypocellular AML were older than those with non-hypocellular AML (median age: 59 vs 49 years; P < .001) and presented with leukopenia more frequently (mean white blood cell count: 5810/µL vs 40549/µL; P < .001). There was no difference between patients with and without hypocellular AML in terms of the presence of antecedent hematologic disorders (5.9% vs 5.3%; P  = .809). FLT3-ITD and NPM1 mutations were less common in hypocellular than non-hypocellular AML (FLT3-ITD mutations: 1.2% vs 14.3%, P < .001; NPM1 mutations: 0% vs 9.5%, P = .019). No differences were seen between the hypocellular and non-hypocellular AML groups in the complete remission rate (53.9% vs 61.3%, P = .139) or early death rate (defined as any death before 8 weeks; 14.7% vs 13.0%, P = .629). The OS and EFS did not differ between the hypocellular and non-hypocellular AML groups (median OS: 16 vs 23 months, P = .169; median EFS: 6 vs 9 months, P = .215). Hypocellular AML is more frequently observed in older-aged patients and have fewer FLT3-ITD and NPM1 mutation, but the clinical outcomes of hypocellular AML do not differ from those of non-hypocellular AML.


Assuntos
Leucemia Mieloide Aguda/classificação , Leucemia Mieloide Aguda/mortalidade , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Leucemia Mieloide Aguda/epidemiologia , Masculino , Pessoa de Meia-Idade , Nucleofosmina , Prognóstico , Sistema de Registros/estatística & dados numéricos , Indução de Remissão , República da Coreia/epidemiologia , Estudos Retrospectivos
4.
ACS Nano ; 14(11): 14971-14988, 2020 11 24.
Artigo em Inglês | MEDLINE | ID: mdl-32880442

RESUMO

The liver is one of the most common sites of breast cancer metastasis and is associated with high lethality. Although the interaction between tumor cells and their microenvironment at metastatic sites has been recognized as a key regulator of tumor progression, the underlying mechanism is not fully elucidated. Here, we describe a three-dimensional (3D) microfluidic human liver-on-a-chip (liver-chip) that emulates the formation of a premetastatic niche to investigate the roles of breast cancer-derived extracellular vesicles (EVs) in liver metastasis. We demonstrate that breast cancer-derived EVs activate liver sinusoidal endothelial cells (LSECs) in the liver-chip, inducing endothelial to mesenchymal transition and destruction of vessel barriers. In addition, we show that transforming growth factor ß1 (TGFß1) in breast cancer-derived EVs upregulates fibronectin, an adhesive extracellular matrix protein, on LSECs, which facilitates the adhesion of breast cancer cells to the liver microenvironment. Furthermore, we observed that EVs isolated from triple-negative breast cancer (TNBC) patients with liver metastasis contain higher TGFß1 levels and induce adhesion of more breast cancer cells to the 3D human liver-chip than do EVs isolated from healthy donors or nonmetastatic TNBC patients. These findings provide a better understanding of the mechanisms through which breast cancer-derived EVs guide secondary metastasis to the liver. Furthermore, the 3D human liver-chip described in this study provides a platform to investigate the mechanisms underlying secondary metastasis to the liver and possible therapeutic strategies.


Assuntos
Vesículas Extracelulares , Fígado , Neoplasias de Mama Triplo Negativas , Células Endoteliais , Humanos , Dispositivos Lab-On-A-Chip , Fígado/fisiologia , Análise de Sequência com Séries de Oligonucleotídeos , Microambiente Tumoral
5.
Metabolism ; 110: 154302, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32589900

RESUMO

BACKGROUND: Intracellular lipid accumulation is associated with various diseases, particularly cancer. Mitochondrial dysfunction is considered as a cause of lipid accumulation; however, the related underlying mechanism remains unclear. FINDINGS: We found that Von Hippel-Lindau (VHL)-deficiency led to lipid accumulation and mitochondrial dysfunction in renal cell carcinoma cells. Moreover, VHL downregulated ATP-citrate lyase (ACLY), a key enzyme in de novo lipid synthesis, at the transcriptional level, which inhibited intracellular lipid accumulation in human renal carcinoma tissues. We identified PPARγ as the transcription factor regulating ACLY expression by binding to the cis-regulatory site PPRE on its promoter. VHL directly interacted with and promoted ubiquitination of PPARγ, leading to its degradation both in vitro and in vivo, resulting in the downregulation of ACLY. Furthermore, adenovirus-mediated VHL overexpression substantially ameliorated hepatic steatosis induced by a high-fat diet in db/db mice. Importantly, low VHL expression was associated with high ACLY expression and poor prognosis in human liver carcinoma in a dataset in The Cancer Genome Atlas. CONCLUSIONS: VHL plays role in cellular lipid metabolism via regulating mitochondria and targeting PPARγ, a transcription factor for ACLY independent of hypoxia-inducible factor 1α. A novel VHL-PPARγ-ACLY axis and its implication in fatty liver disease and cancer were uncovered.


Assuntos
ATP Citrato (pro-S)-Liase/genética , Metabolismo dos Lipídeos/efeitos dos fármacos , Neoplasias/metabolismo , PPAR gama/metabolismo , Ubiquitinação , Proteína Supressora de Tumor Von Hippel-Lindau/fisiologia , Animais , Linhagem Celular Tumoral , Progressão da Doença , Fígado Gorduroso/metabolismo , Humanos , Camundongos , Complexo de Endopeptidases do Proteassoma/fisiologia , Proteína Supressora de Tumor Von Hippel-Lindau/genética
6.
Anal Chem ; 92(8): 6010-6018, 2020 04 21.
Artigo em Inglês | MEDLINE | ID: mdl-32207920

RESUMO

Tumor-derived extracellular vesicles (EVs) have emerged as a promising source of circulating biomarkers for liquid biopsies. However, understanding the heterogeneous physical and biochemical properties of EVs originating from multiple complex biogenesis pathways remains a major challenge. Here, we introduce EV-Ident for preparation of subpopulations of EVs in three different size fractions: large EVs (EV200 nm; 200-1 000 nm), medium EVs (EV100 nm; 100-200 nm), and small EVs (EV20 nm; 20-100 nm). Furthermore, this technology enables the in situ labeling of fluorescence markers for the protein profiling of individual EVs. As a proof-of-concept, we analyzed the presence of human epidermal growth factor receptor 2 (HER2) and prostate-specific membrane antigen (PSMA) in breast cancer and prostate cancer cell-derived EVs, respectively, using three different size fractions at the single-EV level. By reducing the complexity of EV heterogeneity in each size fraction, we found that HER2-positive breast cancer cells showed the greatest expression of HER2 in EV20 nm, whereas PSMA expression was the highest in EV200 nm derived from PSMA-expressing prostate cancer cells. This increase in HER2 expression in EV20 nm and PSMA expression in EV200 nm was further confirmed in plasma-derived nanoparticles (PNPs) obtained from breast and prostate cancer patients, respectively. Our study demonstrates that single-EV analysis using EV-Ident provides a practical way to understand EV heterogeneity and to successfully identify potent subpopulation of EVs for breast and prostate cancer, which has promising translational implications for cancer theranostics. Furthermore, these findings have the potential to address fundamental questions surrounding the biology and clinical applications of EVs.


Assuntos
Antígenos de Superfície/sangue , Biomarcadores Tumorais/sangue , Neoplasias da Mama/sangue , Vesículas Extracelulares/química , Glutamato Carboxipeptidase II/sangue , Neoplasias da Próstata/sangue , Receptor ErbB-2/sangue , Neoplasias da Mama/diagnóstico , Feminino , Humanos , Masculino , Tamanho da Partícula , Neoplasias da Próstata/diagnóstico , Propriedades de Superfície
7.
Lab Chip ; 20(5): 949-957, 2020 03 03.
Artigo em Inglês | MEDLINE | ID: mdl-31989123

RESUMO

Platelets play crucial roles in hemostasis and immunity. Over the last decades, clinical evidence has revealed the significance of platelets as complementary biomarkers for the detection and treatment of various diseases, including cancer. Due to a lack of well standardized convenient isolation methods for platelets, pre-analytical factors such as complex handling procedures negatively impact the quality of the platelet samples, including overactivation, low purity, and poor reproducibility. This may lead to biased interpretation of various downstream analyses, such as proteomic and genomic analyses. Herein, we describe a fully automated lab-on-a-disc-based method of platelet isolation from a small volume of blood (<1 mL). This method provides higher yields (>4 folds) and purity (>99%) and lower platelet activation than the conventional method. Moreover, it was also superior in the detection of platelet-related RNAs CD41, PF4, and P2Y12 due to lower contamination with white blood cells.


Assuntos
Plaquetas , Dispositivos Lab-On-A-Chip , Patologia Molecular , Proteômica , Reprodutibilidade dos Testes
8.
Sci Rep ; 9(1): 18428, 2019 12 05.
Artigo em Inglês | MEDLINE | ID: mdl-31804589

RESUMO

Transmitted light microscopy can readily visualize the morphology of living cells. Here, we introduce artificial-intelligence-powered transmitted light microscopy (AIM) for subcellular structure identification and labeling-free functional analysis of live cells. AIM provides accurate images of subcellular organelles; allows identification of cellular and functional characteristics (cell type, viability, and maturation stage); and facilitates live cell tracking and multimodality analysis of immune cells in their native form without labeling.


Assuntos
Microscopia Intravital/métodos , Redes Neurais de Computação , Animais , Linhagem Celular Tumoral , Células Dendríticas , Feminino , Humanos , Microscopia Intravital/instrumentação , Camundongos , Microscopia de Fluorescência/instrumentação , Microscopia de Fluorescência/métodos , Organelas , Cultura Primária de Células
9.
Opt Express ; 19(23): 23188-201, 2011 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-22109198

RESUMO

We study experimentally and numerically the dynamics of a recently found topological phase transition for discrete quadratic solitons with linearly coupled SH waves. We find that, although no stationary states are excited in the experimental situation, the generic feature of the phase transition of the SH is preserved. By utilizing simulations of the coupled mode equations we identify the complex processes leading to the phase transition involving spatial focusing and the generation of new frequency components. These distinct signatures of the dynamic phase transition are also demonstrated experimentally.

10.
Jpn J Clin Oncol ; 38(2): 134-9, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18263652

RESUMO

BACKGROUND: The prevalence of AIDS-related lymphoma (ARL) is increasing in South Korea. The aim of this study is to identify the clinical features of ARL in South Korea. METHODS: From 1998 through 2006, we retrospectively analysed a total of 23 cases of ARL from seven institutions. RESULTS: The patients consisted of 20 males and 3 females at a median age of 40 (range, 20-72) on diagnosis of AIDS. ARL developed at their median age of 41 (range, 24-72). The histological diagnosis was aggressive B cell lymphoma in the majority, but rare T cell and NK/T cell lymphoma were also included. Ten of 23 (43.5%) was receiving highly active anti-retroviral therapy (HAART) before the diagnosis of ARL. Fifteen of twenty-three patients were given combination chemotherapy with/without radiation, four were given radiation alone, and four did not receive any treatment against medical advice. Of 20 patients followed-up, nine were alive in remission, two alive in disease, one died of treatment related complication, four died of progressive lymphoma, four died of AIDS related causes. The response to treatment included CR in eight (44.4%), PR in four (22.2%) and PD in three (16.7%). The response to HARRT was evaluable in 13 patients based on CD4+ cell count and HIV viral load, among which nine (69.2%) responded. Estimated median survival time was 43.9 months. CONCLUSIONS: Although the population of patients is small, this is the first clinical data analyses of Korean ARL patients. As a substantial portion of the patients remains alive disease free, the impact of HAART on the clinical course of ARL needs further follow-up and evaluation.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Linfoma Relacionado a AIDS/epidemiologia , Linfoma Relacionado a AIDS/terapia , Adulto , Idoso , Quimioterapia Adjuvante , Feminino , Humanos , Coreia (Geográfico)/epidemiologia , Linfoma Relacionado a AIDS/tratamento farmacológico , Linfoma Relacionado a AIDS/radioterapia , Linfoma de Células B/epidemiologia , Linfoma de Células B/terapia , Linfoma de Células T/epidemiologia , Linfoma de Células T/terapia , Masculino , Pessoa de Meia-Idade , Radioterapia Adjuvante , Estudos Retrospectivos , Análise de Sobrevida , Resultado do Tratamento
11.
Int J Hematol ; 83(4): 309-13, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16757429

RESUMO

The proteasome inhibitor bortezomib has demonstrated clinical activity in patients with multiple myeloma (MM). Adverse events, including thrombocytopenia and peripheral neuropathy, have affected 30% to 60% of patients overall, and interrupted therapy in 10% to 20%. No prior toxicity data are available for Asian patients who have used bortezomib for MM. We used National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0, to review the clinical records of patients with an MM diagnosis from 25 centers in Korea. The included patients were treated with bortezomib alone or in combination with other agents, including thalidomide. Ninety-five MM patients were treated. The patients had a median age of 60 years (range, 42-77 years). The median number of previous treatments was 3 (range, 0-10), and 39% of the patients had been treated with 4 or more major classes of agents, including thalidomide (67%), and autologous stem cell transplantation (51%). Regimens included bortezomib only in 38 patients (40%), bortezomib plus dexamethasone in 34 patients (36%), and bortezomib plus a thalidomide-containing regimen in 23 patients (24%). The analysis of patient response to therapy revealed a complete response (CR) or a near-CR in 31 patients (33%) and a partial response in 30 patients (32%), for an objective response rate of 65% in 93 patients. The most common adverse events reported were thrombocytopenia (47%), sensory neuropathy (42%), anemia (31%), and leukopenia (31%). Thirteen patients (14%) stopped therapy because of adverse events (neuropathy, 8; infection, 4; diarrhea, 1). Neuropathy greater than grade 2 was more frequent in patients who received 4 or more prior therapy regimens (17/37) than in those who received 3 or fewer (14/58). In addition, therapy including thalidomide was significantly correlated with neuropathy of grades 1 to 3 (P = .001). We identified 6 therapy-related deaths (6%) within 20 days after the last dose of bortezomib. The causes of death were infection in 3 patients, disease progression in 2 patients, and suicide in 1 patient. The incidences of thrombocytopenia and neurotoxicity were similar; however, gastrointestinal toxicities were relatively low in Korean patients compared with those reported in Western studies. Significant neuropathy was associated with the number of prior regimens and combination with thalidomide. These findings provide useful information for clinicians and patients using bortezomib.


Assuntos
Antineoplásicos/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Ácidos Borônicos/efeitos adversos , Mieloma Múltiplo/terapia , Pirazinas/efeitos adversos , Adulto , Idoso , Antineoplásicos/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Povo Asiático , Ácidos Borônicos/administração & dosagem , Bortezomib , Dexametasona/administração & dosagem , Dexametasona/efeitos adversos , Feminino , Humanos , Coreia (Geográfico) , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/complicações , Mieloma Múltiplo/mortalidade , Pirazinas/administração & dosagem , Estudos Retrospectivos , Transplante de Células-Tronco/mortalidade , Talidomida/administração & dosagem , Talidomida/efeitos adversos , Transplante Autólogo
12.
Opt Express ; 14(12): 5508-16, 2006 Jun 12.
Artigo em Inglês | MEDLINE | ID: mdl-19516718

RESUMO

We report the first observation of discrete quadratic surface solitons in self-focusing and defocusing periodically poled lithium niobate waveguide arrays. By operating on either side of the phase-matching condition and using the cascading nonlinearity, both in-phase and staggered discrete surface solitons were observed. This represents the first experimental demonstration of staggered/gap surface solitons at the interface of a semi-infinite nonlinear lattice. The experimental results were found to be in good agreement with theory.

13.
Phys Rev Lett ; 95(5): 053902, 2005 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-16090877

RESUMO

We report the first observation of discrete Talbot revivals in one-dimensional waveguide arrays. Unlike continuous systems where the Talbot self-imaging effect always occurs irrespective of the pattern period, in discrete configurations this process is only possible for a specific set of periodicities. Recurrence of different input periodic patterns is observed in good agreement with theory.

14.
Opt Lett ; 30(9): 1033-5, 2005 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-15906994

RESUMO

We observe highly localized solitons in periodically poled lithium niobate waveguide arrays close to phase matching for second-harmonic generation. With fundamental and second-harmonic input in one channel the response indicates two distinguishable propagation schemes. Depending on the relative phase between the two input waves, a self-trapped beam emerges, resembling closely either the in- or the out-of-phase quadratic eigenmode of a single waveguide. A stable soliton propagates when the input waves are in phase.

15.
Oncol Rep ; 13(2): 265-71, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15643509

RESUMO

Mutations of p53, K-ras, c-kit, and beta-catenin gene were examined in 100 cases of sinonasal NK/T-cell lymphoma (NKTCL) from Korea and Japan. Age of patients ranged from 12 to 72 (median 41.0) in Korea and 27 to 82 (median 61.0) years in Japan. Gene mutations were analyzed on paraffin-embedded specimens by PCR-SSCP followed by direct sequencing. p53 is a well-known tumor suppressor gene. c-kit gene encodes a receptor tyrosine kinase, which plays a crucial role in proliferation and differentiation of hematopoietic stem cells. Mutations of K-ras and beta-catenin are frequently observed in cancers. Thirteen of 42 (31.0%) cases from Korea and 36 of 58 (62.1%) from Japan had p53 mutations, showing significant differences in the incidence of p53 mutation between two countries. Of the Japanese cases 18 (31.0%) had mutations in exon 4, while only 3 cases (7.1%) were found in Korea cases (p<0.01 by chi2 test). K-ras, c-kit and beta-catenin mutations were also found in higher incidence in Japanese cases. In conclusion, different frequency of p53 mutations with different pattern of exon involvement and difference in age of disease onset is evident between sinonasal NKTCL in Korea and Japan.


Assuntos
Genes p53 , Genes ras , Linfoma de Células T/genética , Neoplasias dos Seios Paranasais/genética , Proteínas Proto-Oncogênicas c-kit/genética , Adolescente , Adulto , Idoso , Criança , Proteínas do Citoesqueleto , Feminino , Granuloma Letal da Linha Média/genética , Humanos , Japão , Células Matadoras Naturais , Coreia (Geográfico) , Masculino , Pessoa de Meia-Idade , Mutação , Transativadores , beta Catenina
16.
Opt Express ; 13(20): 7794-9, 2005 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-19498807

RESUMO

Parametric gain associated with discrete modulational instability due to the second order nonlinearity chi(2)(-2omega;omega,omega) was investigated experimentally in periodically poled lithium niobate arrays of weakly coupled channel waveguides for conditions of both positive and negative phase-mismatch for second harmonic generation.

17.
Opt Lett ; 28(23): 2348-50, 2003 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-14680178

RESUMO

We report the experimental demonstration of spatial nonlinear beam displacement caused by an interface between periodically modulated and uniform quadratic nonlinearity. We observe intensity- and phase-mismatch-dependent spatial beam displacement at 1548 nm in lithium niobate waveguides. The device has the potential to provide a soliton-emission-based, ultrafast all-optical switch.

18.
Stem Cells ; 20(1): 73-9, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11796924

RESUMO

Thrombopoietin (TPO) is widely used for ex vivo expansion of hematopoietic stem cells. Previously, we have reported that TPO induces a characteristic pattern of apoptosis, and the TPO-induced apoptosis is closely associated with megakaryocyte (MK) differentiation. In the present study, several cytokines, flt3-ligand, stem cell factor (SCF), interleukin-3 (IL-3), IL-6, IL-11, leukemia inhibitory factor, G-CSF, and erythropoietin, which are known to affect megakaryocytopoiesis, have been evaluated to elucidate their effects on the TPO-induced apoptosis. Measurement of apoptosis by flow cytometry revealed that only SCF absolutely reduced the TPO-induced apoptosis in MK fractions, particularly in the late phase of ex vivo expansion. Platelet production was demonstrated by electron microscopy in a later phase when SCF was added. Simultaneous measurement of DNA contents with immunophenotyping demonstrated a significant increase in polyploidization in the CD41+ cell fraction when cultured with SCF. These results suggested that SCF not only inhibited premature senescence but also enhanced maturation of the differentiating cells of MK lineage during ex vivo expansion using TPO.


Assuntos
Antígenos CD34/biossíntese , Apoptose , Sangue Fetal/metabolismo , Megacariócitos/citologia , Megacariócitos/metabolismo , Fator de Células-Tronco/metabolismo , Trombopoetina/biossíntese , Divisão Celular , Linhagem da Célula , Células Cultivadas , Meios de Cultura Livres de Soro/farmacologia , Eritropoetina/biossíntese , Citometria de Fluxo , Fator Estimulador de Colônias de Granulócitos/biossíntese , Inibidores do Crescimento/biossíntese , Humanos , Interleucina-11/biossíntese , Interleucina-3/biossíntese , Interleucina-6/biossíntese , Fator Inibidor de Leucemia , Linfocinas/biossíntese , Proteínas de Membrana/biossíntese , Microscopia Eletrônica , Ploidias , Fator de Células-Tronco/biossíntese , Fatores de Tempo
19.
Opt Lett ; 27(24): 2182-4, 2002 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-18033476

RESUMO

We show numerically and experimentally that spatial trapping can be induced in quadratic media even if the pump pulse's duration is shorter than the group-delay mismatch between fundamental wave and second-harmonic components. The influence of phase mismatch and pulse power on the trapping effect is discussed. Spatial, temporal, and spectral behaviors that accompany self-trapped propagation are highlighted.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...